Technology | 2009.10.21
Life Technologies Delivers Enhanced Next-Generation Genomic Analysis Technology for Large-Scale Resequencing Projects
CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE) today announced the commercial availability of the SOLiD™ 3 Plus System, an enhanced next-generation genomic analysis platform designed to allow researchers to move one step closer to performing mainstream sequencing of personal genomes for clinical research and personalized medicine. The technical enhancements to SOLiD 3 Plus include higher throughput, decreased run costs, and faster
For more information, please visit
http://www.businesswire.com/news/home/20091021005136/en
